Presentation THT 2024 Potential Benefits of Decreasing HR: Adjuntive Therapies to Pumps Presenter: Hidetaka Morita March 05, 2024
Presentation THT 2024 Cardiogenic Shock: The Urgent Need for Innovation in Devices and Technologies for Shock Presenter: Navin K. Kapur March 05, 2024
Presentation THT 2024 Clinical Outcomes and Adverse Events in Cardiogenic Shock Patients who Recieved Impella 5.0/5.5: A Report from the Cardiogenic Shock Working Group Presenter: Justin Fried March 05, 2024
Presentation THT 2024 Cardiogenic Shock in Stress Induced Cardiomyopathy Complicated by Left Ventricular Outflow Obstruction: Hemodynamic-Tailored Management Presenter: Mary Quien March 05, 2024
Presentation THT Abstracts 2024 Association Between Inpatient Percutaneous Coronary Intervention Volume and Thirty-Day Readmissions After Acute†Myocardial Infarction- Cardiogenic Shock Presenter: Kannu Bansal March 04, 2024
Presentation THT Abstracts 2024 Impact of Cumulative Vasopressor and Inotrope Medications on Outcomes in Cardiogenic Shock: A Cardiogenic Shock Working Group Report Presenter: Saraschandra Vallabhajosyula March 04, 2024
Presentation THT Abstracts 2024 Advanced Therapy Eligibility in Patients with Axillary Impella for Cardiogenic Shock Presenter: McKenzie Sicke March 04, 2024
Presentation THT Abstracts 2024 The Clinical Effectiveness of Pulmonary Artery Catheter in Patients with Cardiogenic Shock Presenter: Atsuyuki Watanabe March 04, 2024
Presentation THT Abstracts 2024 Early Feasibility Study of the Vivasure PerQsealÆ Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention Presenter: Rajiv Tayal March 04, 2024
Presentation THT Abstracts 2024 ImpellaÆ Use Improves Hemodynamics for Cardiogenic Shock from Ventricular Septal Defect (VSD) Presenter: Brent Medoff March 04, 2024
Presentation THT Abstracts 2024 Impact of Cardiogenic Shock Progression on Outcomes: SCAI B is Bad 2013 A Cardiogenic Shock Working Group Report Presenter: Van-Khue Ton March 04, 2024
Presentation THT Abstracts 2024 Temporal Trends of Vasopressor and Inotrope Use in Cardiogenic Shock: A Cardiogenic Shock Working Group Report Presenter: Saraschandra Vallabhajosyula March 04, 2024
Presentation THT Abstracts 2024 Assessment of patients with cardiogenic shock requiring veno-arterial extracorporeal membrane oxygenation upgrade from Impella 5.5 univentricular support Presenter: James Schurr March 04, 2024
Presentation THT 2024 Early Feasibility Study of the Vivasure PerQseal® Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention Presenter: Rajiv Tayal March 04, 2024
News Opinion Off Script Passion, Persistence, and Generosity: Remembering Alain Cribier Martin B. Leon, MD February 27, 2024
Presentation Miami Valves 2024 Acute Myocardial Infarction Complicated with Cardiogenic Shock Presenter: Miguel Martillo Correa February 03, 2024
Presentation Miami Valves 2024 National Cardiogenic Shock Initiative: What we’ve learned? Presenter: Alejandro Lemor February 03, 2024
Presentation Miami Valves 2024 Lessons Learned & Best Practices in Cardiogenic Shock Presenter: Abdulla A. Damluji February 01, 2024
Presentation Miami Valves 2024 Critical Aortic Valve Stenosis of Severely Calcific Bicuspid Valve with Acute Cardiogenic Shock Presenter: Victor Razuk February 01, 2024
Presentation Miami Valves 2024 Mitral Transcatheter Edge-to-Edge Repair in Cardiogenic Shock: A Systematic Review and Meta-Analysis Presenter: Fabricio Malaguez Webber February 01, 2024